We are live on ! Find out more
ACB

Aristotle Capital Boston Portfolio holdings

AUM $1.61B
1-Year Est. Return 19.82%
This Fund
S&P 500
This Quarter Est. Return
+11.47%
1 Year Est. Return
+19.82%
3 Year Est. Return
+51.6%
5 Year Est. Return
+74.11%
10 Year Est. Return
+400.29%
AUM
$730M
AUM Growth
+$169M
Cap. Flow
+$111M
Cap. Flow %
15.2%
Top 10 Hldgs %
18.73%
Holding
130
New
27
Increased
88
Reduced
13
Closed
2

Sector Composition

Rank Sector Weight
1 Industrials 19.94%
2 Technology 17.32%
3 Financials 16.14%
4 Healthcare 11.97%
5 Consumer Discretionary 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AIN icon
76
Albany International
AIN
$2.09B
$4.44M 0.61%
95,800
+13,295
+16% +$586K
PIR
77
DELISTED
Pier 1 Imports, Inc.
PIR
$4.32M 0.59%
25,283
+3,813
+18% +$442K
IWO icon
78
iShares Russell 2000 Growth ETF
IWO
$14.1B
$4.31M 0.59%
+27,981
New +$4.18M
CVGI icon
79
Commercial Vehicle Group
CVGI
$147M
$4.27M 0.59%
772,600
+2,518
+0.3% +$13.4K
OII icon
80
Oceaneering
OII
$4.64B
$4.15M 0.57%
147,262
+25,566
+21% +$689K
CFNL
81
DELISTED
Cardinal Financial Corp
CFNL
$4.1M 0.56%
125,169
+19,716
+19% +$583K
HLF icon
82
Herbalife
HLF
$1.3B
$4.08M 0.56%
169,704
+30,808
+22% +$841K
MRT
83
DELISTED
MedEquities Realty Trust, Inc.
MRT
$4.08M 0.56%
367,770
+7,606
+2% +$85K
RES icon
84
RPC Inc
RES
$1.13B
$4.07M 0.56%
205,577
+178,678
+664% +$3.35M
AZZ icon
85
AZZ Inc
AZZ
$4.24B
$4.03M 0.55%
63,108
+11,160
+21% +$673K
NUS icon
86
Nu Skin
NUS
$257M
$3.97M 0.54%
83,132
+12,618
+18% +$707K
SLGN icon
87
Silgan Holdings
SLGN
$4.51B
$3.91M 0.54%
152,722
+21,364
+16% +$537K
CYNO
88
DELISTED
Cynosure, Inc. Class A
CYNO
$3.87M 0.53%
84,899
+6,033
+8% +$276K
TIVO
89
DELISTED
Tivo Inc
TIVO
$3.85M 0.53%
184,127
+30,454
+20% +$619K
MKTX icon
90
MarketAxess Holdings
MKTX
$4.47B
$3.39M 0.46%
23,081
+3,497
+18% +$556K
COLB icon
91
Columbia Banking Systems
COLB
$8.71B
$3.36M 0.46%
75,242
+5,320
+8% +$201K
TBBK icon
92
The Bancorp
TBBK
$2.81B
$3.32M 0.45%
422,057
+43,208
+11% +$309K
UTL icon
93
Unitil
UTL
$989M
$3.28M 0.45%
72,335
+62,253
+617% +$2.6M
MNRO icon
94
Monro
MNRO
$415M
$3.21M 0.44%
56,028
+9,146
+20% +$527K
TCBI icon
95
Texas Capital Bancshares
TCBI
$4.28B
$2.5M 0.34%
31,843
+2,206
+7% +$149K
CAI
96
DELISTED
CAI International, Inc.
CAI
$2.49M 0.34%
287,583
-6,827
-2% -$59.7K
AGI icon
97
Alamos Gold
AGI
$12B
$2.44M 0.33%
356,325
+52,063
+17% +$366K
CCEC
98
Capital Clean Energy Carriers
CCEC
$1.37B
$2.2M 0.3%
98,782
+6,575
+7% +$141K
SGM
99
DELISTED
Stonegate Mortgage Corporation
SGM
$1.91M 0.26%
319,773
-20,585
-6% -$96.2K
ACHC icon
100
Acadia Healthcare
ACHC
$2.55B
$1.82M 0.25%
+54,903
New +$2.13M

Similar funds

Aristotle Capital Boston's Q4 2016 Portfolio in Review

As of Q4 2016, Aristotle Capital Boston held 130 positions worth $730M, up 30% from $561M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Aristotle Capital Boston deployed $111M of net new capital in Q4 2016, opening 27 new positions and adding to 88 existing holdings. Its largest new stake was Envision Healthcare Holdings Inc: 184,286 shares worth $11.7M.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, down from 21% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Wabash National, an estimated $1.35M trimmed.

  • Aristotle Capital Boston's largest Q4 2016 buy was Envision Healthcare Holdings Inc: 184,286 shares worth $11.7M.
  • Aristotle Capital Boston added most to iShares Russell 2000 ETF in Q4 2016, an estimated $9.41M increase.
  • Aristotle Capital Boston's biggest Q4 2016 reduction was Wabash National, cutting an estimated $1.35M.
  • Aristotle Capital Boston fully exited Amsurg Corp in Q4 2016, selling an estimated $10.2M.
  • Aristotle Capital Boston's ten largest holdings make up 19% of its $730M portfolio in Q4 2016.
  • Aristotle Capital Boston opened 27 new positions and closed 2 in Q4 2016.
  • Aristotle Capital Boston's portfolio value rose 30% quarter-over-quarter to $730M.

Based on Aristotle Capital Boston's 13F filing for Q4 2016, filed 14 Feb 2017.